Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2661 | 2182 | 50.3 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
2661 | 1 | HIGH DENSITY LIPOPROTEIN//HDL//REVERSE CHOLESTEROL TRANSPORT | 2182 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HIGH DENSITY LIPOPROTEIN | authKW | 787769 | 14% | 18% | 313 |
2 | HDL | authKW | 601122 | 14% | 15% | 295 |
3 | REVERSE CHOLESTEROL TRANSPORT | authKW | 461163 | 7% | 21% | 156 |
4 | ANACETRAPIB | authKW | 417285 | 2% | 76% | 39 |
5 | APOLIPOPROTEIN A I | authKW | 409763 | 8% | 17% | 176 |
6 | DALCETRAPIB | authKW | 310953 | 2% | 67% | 33 |
7 | APOLIPOPROTEIN A I MIMETIC PEPTIDES | authKW | 287837 | 1% | 86% | 24 |
8 | DYSFUNCTIONAL HDL | authKW | 286622 | 1% | 79% | 26 |
9 | CHOLESTEROL EFFLUX | authKW | 275113 | 5% | 17% | 113 |
10 | TORCETRAPIB | authKW | 265138 | 2% | 56% | 34 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 15331 | 25% | 0% | 543 |
2 | Cardiac & Cardiovascular System | 12821 | 31% | 0% | 667 |
3 | Hematology | 1314 | 8% | 0% | 179 |
4 | Biochemistry & Molecular Biology | 1075 | 22% | 0% | 480 |
5 | Endocrinology & Metabolism | 973 | 9% | 0% | 202 |
6 | Pharmacology & Pharmacy | 735 | 13% | 0% | 285 |
7 | Medical Laboratory Technology | 461 | 3% | 0% | 58 |
8 | Medicine, Research & Experimental | 269 | 5% | 0% | 116 |
9 | Medicine, General & Internal | 191 | 6% | 0% | 132 |
10 | Nutrition & Dietetics | 159 | 3% | 0% | 63 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROT SENSOR | 165158 | 1% | 54% | 22 |
2 | LIPID ARTERIOSCLEROSIS SCI | 120930 | 1% | 79% | 11 |
3 | LIPOPROT METAB SECT | 87065 | 1% | 33% | 19 |
4 | ATHEROSCLEROSIS UNIT | 76451 | 3% | 8% | 66 |
5 | DYSLIPIDEMIA INFLAMMAT ATHEROSCLEROSIS UNIT | 68880 | 0% | 62% | 8 |
6 | LIPID GRP | 61982 | 1% | 18% | 25 |
7 | PROGRAM SERUM BIOMED EDUC TEAM BK21PLUS | 55966 | 0% | 67% | 6 |
8 | UMR 939 | 55966 | 0% | 67% | 6 |
9 | E GROSSI PAOLETTI | 48636 | 1% | 17% | 20 |
10 | ENDOCRINOL METAB DIABET MOL MED | 43723 | 0% | 63% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL LIPIDOLOGY | 49509 | 2% | 7% | 48 |
2 | JOURNAL OF LIPID RESEARCH | 35908 | 7% | 2% | 148 |
3 | CURRENT OPINION IN LIPIDOLOGY | 30714 | 2% | 4% | 54 |
4 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 29655 | 6% | 2% | 126 |
5 | ATHEROSCLEROSIS | 21829 | 6% | 1% | 129 |
6 | CURRENT ATHEROSCLEROSIS REPORTS | 14260 | 1% | 4% | 26 |
7 | CLINICAL LIPIDOLOGY | 8213 | 1% | 4% | 15 |
8 | FUTURE LIPIDOLOGY | 4354 | 0% | 4% | 7 |
9 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 3482 | 1% | 1% | 26 |
10 | LIPIDS IN HEALTH AND DISEASE | 3312 | 1% | 1% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIGH DENSITY LIPOPROTEIN | 787769 | 14% | 18% | 313 | Search HIGH+DENSITY+LIPOPROTEIN | Search HIGH+DENSITY+LIPOPROTEIN |
2 | HDL | 601122 | 14% | 15% | 295 | Search HDL | Search HDL |
3 | REVERSE CHOLESTEROL TRANSPORT | 461163 | 7% | 21% | 156 | Search REVERSE+CHOLESTEROL+TRANSPORT | Search REVERSE+CHOLESTEROL+TRANSPORT |
4 | ANACETRAPIB | 417285 | 2% | 76% | 39 | Search ANACETRAPIB | Search ANACETRAPIB |
5 | APOLIPOPROTEIN A I | 409763 | 8% | 17% | 176 | Search APOLIPOPROTEIN+A+I | Search APOLIPOPROTEIN+A+I |
6 | DALCETRAPIB | 310953 | 2% | 67% | 33 | Search DALCETRAPIB | Search DALCETRAPIB |
7 | APOLIPOPROTEIN A I MIMETIC PEPTIDES | 287837 | 1% | 86% | 24 | Search APOLIPOPROTEIN+A+I+MIMETIC+PEPTIDES | Search APOLIPOPROTEIN+A+I+MIMETIC+PEPTIDES |
8 | DYSFUNCTIONAL HDL | 286622 | 1% | 79% | 26 | Search DYSFUNCTIONAL+HDL | Search DYSFUNCTIONAL+HDL |
9 | CHOLESTEROL EFFLUX | 275113 | 5% | 17% | 113 | Search CHOLESTEROL+EFFLUX | Search CHOLESTEROL+EFFLUX |
10 | TORCETRAPIB | 265138 | 2% | 56% | 34 | Search TORCETRAPIB | Search TORCETRAPIB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ROSENSON, RS , BREWER, HB , ANSELL, BJ , BARTERT, P , CHAPMAN, MJ , HEINECKE, JW , KONTUSH, A , TALL, AR , WEBB, NR , (2016) DYSFUNCTIONAL HDL AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE.NATURE REVIEWS CARDIOLOGY. VOL. 13. ISSUE 1. P. 48 -60 | 74 | 62% | 42 |
2 | LEMAN, LJ , MARYANOFF, BE , GHADIRI, MR , (2014) MOLECULES THAT MIMIC APOLIPOPROTEIN A-I: POTENTIAL AGENTS FOR TREATING ATHEROSCLEROSIS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 6. P. 2169 -2196 | 146 | 56% | 18 |
3 | SANTOS-GALLEGO, CG , BADIMON, JJ , ROSENSON, RS , (2014) BEGINNING TO UNDERSTAND HIGH-DENSITY LIPOPROTEINS.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 43. ISSUE 4. P. 913 -+ | 116 | 66% | 24 |
4 | ANNEMA, W , VON ECKARDSTEIN, A , (2013) HIGH-DENSITY LIPOPROTEINS - MULTIFUNCTIONAL BUT VULNERABLE PROTECTIONS FROM ATHEROSCLEROSIS.CIRCULATION JOURNAL. VOL. 77. ISSUE 10. P. 2432-2448 | 115 | 49% | 45 |
5 | JOY, TR , (2012) NOVEL HDL-BASED THERAPEUTIC AGENTS.PHARMACOLOGY & THERAPEUTICS. VOL. 135. ISSUE 1. P. 18-30 | 75 | 88% | 17 |
6 | RYE, KA , BARTER, PJ , (2014) THEMATIC REVIEW SERIES: HIGH DENSITY LIPOPROTEIN STRUCTURE, FUNCTION, AND METABOLISM CARDIOPROTECTIVE FUNCTIONS OF HDLS.JOURNAL OF LIPID RESEARCH. VOL. 55. ISSUE 2. P. 168-179 | 74 | 60% | 64 |
7 | SVIRIDOV, D , REMALEY, AT , (2015) HIGH-DENSITY LIPOPROTEIN MIMETICS: PROMISES AND CHALLENGES.BIOCHEMICAL JOURNAL. VOL. 472. ISSUE . P. 249 -259 | 80 | 78% | 2 |
8 | RADER, DJ , TOTH, PP , BARTER, PJ , ROSENSON, RS , BODEN, WE , CHAPMAN, MJ , CUCHEL, M , D'AGOSTINO, RB , DAVIDSON, MH , DAVIDSON, WS , ET AL (2013) HIGH-DENSITY LIPOPROTEINS: A CONSENSUS STATEMENT FROM THE NATIONAL LIPID ASSOCIATION.JOURNAL OF CLINICAL LIPIDOLOGY. VOL. 7. ISSUE 5. P. 484 -525 | 104 | 46% | 73 |
9 | KINGWELL, BA , CHAPMAN, MJ , KONTUSH, A , MILLER, NE , (2014) HDL-TARGETED THERAPIES: PROGRESS, FAILURES AND FUTURE.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 6. P. 445 -464 | 88 | 45% | 77 |
10 | PIRILLO, A , NORATA, GD , CATAPANO, AL , (2013) TREATING HIGH DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C): QUANTITY VERSUS QUALITY.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 21. P. 3841-3857 | 108 | 55% | 9 |
Classes with closest relation at Level 1 |